Politician trade (House)

Dexcom (DXCM): Rep. Robert P. Bresnahan Jr. (PA08) disclosed a purchase $1K–$15K

Rep. Robert P. Bresnahan Jr. (PA08) disclosed a purchase of Dexcom in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
25 days
Disclosure lag
Traded
May 15, 2025
Disclosed
Jun 9, 2025

What stands out in this filing

  • Disclosed 25 days after the trade.
  • Owner named on the report: Filer.
  • 3 disclosures on DXCM by this member on file.
  • 1 other member of Congress disclosed a trade in DXCM within 90 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 25, 2025CongressDisclosed purchase of DXCM — reported range $1,001 - $15,000
  2. Mar 17, 2025InsiderDirector sold ~$25K of DXCM shares in the open market
  3. Apr 7, 2025CongressDisclosed sale of DXCM — reported range $15,001 - $50,000
  4. Apr 8, 2025CongressDisclosed sale of DXCM — reported range $1,001 - $15,000
  5. Apr 9, 2025FDAFDA device clearance: Dexcom G7 15 Day Continuous Glucose Monitoring System
  6. May 5, 2025FDARecall: Dexcom G7 iOS Application, Ref: SW12300 used in conjunction with the Dexcom G7 Continuous Glucose Monitoring (CGM) system
  7. May 8, 2025CongressDisclosed purchase of DXCM — reported range $15,001 - $50,000
  8. May 12, 2025FDARecall: Dexcom One+ Continuous Glucose Monitoring System, SKU(Part Number): STK-D7-013 (MT28285-1), STK-D7-014 (MT28285-1), STK-D7-103 (MT28285-2)
  9. May 12, 2025FDARecall: Dexcom One Continuous Glucose Monitoring System, SKUs(Part Number): STK-DO-006 (MT27409-1), STK-DO-013 (MT27409-1), STK-DO-103 (MT27409-2), STK-DO-109 (MT27409…
  10. May 12, 2025FDARecall: Dexcom G6 Glucose Receiver, SKUs (Part Number): STK-FM-001 (MT27408-1) & STK-FR-001 (MT27408-1)
  11. May 12, 2025FDARecall: Dexcom G7 Glucose Receiver, SKUs (part number): STK-AT-011(MT26403-0), STK-AT-012 (MT26403-0), STK-AT-013 (MT26403-0), STK-GT-001 (MT26403-1), STK-GT-008 (MT26…
  12. May 12, 2025CongressDisclosed sale of DXCM — reported range $15,001 - $50,000
  13. May 15, 2025 · this disclosureCongressDisclosed purchase of DXCM — reported range $1,001 - $15,000

What came next

  1. May 23, 2025InsiderOfficer sold ~$843K of DXCM shares in the open market
  2. May 27, 2025InsiderOfficer sold ~$526K of DXCM shares in the open market
  3. Jun 13, 2025InsiderDirector sold ~$214K of DXCM shares in the open market
  4. Jun 16, 2025Insider · 3 peopleInsiders: 3 sales (~$574K)
  5. Jun 26, 2025InsiderOfficer sold ~$125K of DXCM shares in the open market
  6. Jul 15, 2025Insider · 2 peopleInsiders: 3 sales (~$277K)
  7. Jul 24, 2025FDARecall: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM Android App Model/Catalog Number: SW12299 Software Version: version 2.8.…
  8. Jul 24, 2025FDARecall: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ Android CGM App Model/Catalog Number: SW14245 Software Version: versions…
  9. Jul 24, 2025FDARecall: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: versions 2.8…
  10. Jul 24, 2025FDARecall: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.4…
  11. Jul 24, 2025FDARecall: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: version 2.8.0 an…
  12. Jul 28, 2025InsiderOfficer sold ~$130K of DXCM shares in the open market
  13. Aug 15, 2025Insider · 2 peopleInsiders: 3 sales (~$263K)
  14. Aug 27, 2025Layoff notice · 6290-6350 Sequence Drive San Diego CA 92121Layoff notice filed in CA: 319 employees
  15. Aug 28, 2025FDARecall: Brand Name: Dexcom G6 Continuous Glucose Monitoring System Product Name: Dexcom G6 and G6 Pro Android US CGM App Model/Catalog Number: SW11678 Software Version…
  16. Sep 2, 2025InsiderOfficer sold ~$358K of DXCM shares in the open market
  17. Sep 4, 2025InsiderOfficer sold ~$117K of DXCM shares in the open market
  18. Sep 5, 2025InsiderDirector sold ~$54K of DXCM shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Dexcom

For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DXCM page.

Other recent filings by Rep. Robert P. Bresnahan Jr. (PA08)

The full history of Rep. Robert P. Bresnahan Jr. (PA08) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Dexcom (DXCM) stock, and how much?

Rep. Robert P. Bresnahan Jr. (PA08) disclosed a purchase of Dexcom in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: May 15, 2025. Disclosed: Jun 9, 2025. That is 25 days between the two dates.

What stands out in this filing?

Disclosed 25 days after the trade. Owner named on the report: Filer. 3 disclosures on DXCM by this member on file.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Dexcom recently?

For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the DXCM page.

Does this mean DXCM stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Dexcom

Everything OQRO holds on this company is on its DXCM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data